- Welcome and introduction:
Melanie Carr, EMA Head of Stakeholders and Communication 1:26
June Raine, PRAC chair 2:50

- Public hearing rules and background information
Juan García Burgos, EMA Head of Public Engagement 6:23
Eva Jirsová, PRAC rapporteur 9:26

- Speakers interventions, general public
Elizabeth Carmouche, Belgium 14:30
Manex Bettan Arguinzoniz, Spain 24:54
Richard Cooknell, UK 35:13
Markus Hamedinger, Austria 42:46
Miriam Knight 1, Quinolone Toxicity Support UK 49:48
Julie Le Normand, France 1:04:48
Elsa Leitão, Germany 1:13:15
Jaroslaw Linka, Poland 1:24:13
Andrea Noya, Italy 1:33:25
Joshua Sutton, UK 1:41:15
Miriam van Staveren, The Netherlands 1:49:20
John Crowley, Luxembourg 2:01:08
Enikő Pongrácz, Hungary 2:10:50

- Speakers interventions, pharmaceutical companies
Leo Plouffe, Bayer AG 2:24:50

- Speakers interventions, healthcare professionals and academia
Jamie Wilkinson, Pharmaceutical Group of the European Union (PGEU) 2:40:28
Graham Bothamley, European Respiratory Society (ERS) 2:49:01
Mary McCarthy, European Union of General Practioners (UEMO) 3:00:27
Neal L Millar, Institute of Infection, Immunity and Inflammation, University of Glasgow, UK 3:10:35
Ber Oomen, European Specialist Nurses Organisations (ESNO) 3:25:02
Paul Tulkens, Louvain Drug Research Institute, Belgium 3:31:41
Florian Wagenlehner, European Association of Urology (EAU) 3:38:50
Other speakers 3:39:40

- Wrap up, summary of interventions and next steps
June Raine (PRAC chair) 4:05:39

свернуть